JP Patent

JP7650929B2 — 成人における焦点てんかんの処置のための合成経皮的カンナビジオール

Assigned to ハーモニー・バイオサイエンシズ・マネージメント・インコーポレイテッド · Expires 2025-03-25 · 1y expired

What this patent protects

Patent listed against Qulipta.

Drugs covered by this patent

Patent Metadata

Patent number
JP7650929B2
Jurisdiction
JP
Classification
—
Expires
2025-03-25
Drug substance claim
No
Drug product claim
No
Assignee
ハーモニー・バイオサイエンシズ・マネージメント・インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.